The guidance on the modifications for adult and paediatric allergy services below relates to the winding down of routine services, so that we can better support the wider COVID effort and highlight issues relating to specific diseases and treatments such as immunotherapy, where regular visits are normally required. There is also consideration of the priority groups of patients who will require ongoing access to care and should be first to be considered as services start to normalise. The BSACI have also been working with patient groups to support the dissemination of patient information.


MODIFICATIONS FOR ADULT ALLERGY SERVICES DURING COVID-19 PANDEMIC

MODIFICATIONS FOR PAEDIATRIC ALLERGY SERVICES DURING COVID-19 PANDEMIC

Coronavirus and Allergies – Frequently asked Questions & Answers  (updated 25.05.2020)

Allergy in ICD-11 NL12 Newsletter

The Royal College of Physcians ‘Ethical guidance published for frontline staff dealing with pandemic’

RCPsych  - Top ten messages for supporting healthcare staff during the COVID – 19 Pandemic  

BAD Guidance for Managing Urticaria Patients on Omalizumab during the Coronavirus Pandemic.

BAD - Dermatology Advice Regarding Immunosuppressed Patients: Adults, Paediatrics and Young People 

 Useful sites and Information relating to Covid-19
Royal Colleges:




Latest COVID-19 guidance from the RCGP

 Diseases:



British Society of Gastroenterology

 Patient organisations:




Wellbeing:  

 RCPCH

 Support from the BSACI Nurses group to BSACI nursing members

 



Latest News Headlines

Doctor

Become a BSACI Member...

GPs, Nurses, Allergy Specialists, Dieticians, Generalists

Join BSACI to receive the regular BSACI Allergy Update, have online access to the monthly journal 'Clinical & Experimental Allergy’, download our popular guidelines and a discount to the BSACI Annual Meeting.

Join Now